Certain Shares of Eyez,Inc. are subject to a Lock-Up Agreement Ending on 19-JUN-2023.
June 18, 2023
Share
Certain Shares of Eyez,Inc. are subject to a Lock-Up Agreement Ending on 19-JUN-2023. These Shares will be under lockup for 180 days starting from 21-DEC-2022 to 19-JUN-2023.
Details:
With the offering and the secondary offering by the underwriters, Noriyuki Fukushima, who is the seller and lender, Shinichi Makita and Shoichi Mitani, who are the sellers, Ciel LLC, which is a shareholder of the Company, and the Company Takeshi Imamura, the stock acquisition right holder, will provide the lead managing company with a period of 180 days from the date of execution of the principal underwriting agreement until June 18, 2023, which is the 180th day after the listing (commencement of trading) date (including the day) (hereinafter referred to as During the lock-up period), the Company's shares (including the Company's stock acquisition rights and the Company's common shares acquired by exercising the stock acquisition rights) may not be sold (however, underwritten It has been agreed that the Company will not sell shares of common stock of the Company for sale by purchase and acceptance by third parties, or lending of the Company's common stock for sale by way of over-allotment, etc.).
Eyez Inc is a Japan-based company mainly engaged in the provision of advertising services. The Company's main services include the advertising industry platform MEDIARADAR and word-of-mouth marketing platform trami. MEDIARADAR is a business-to-business (B2B) platform that connects sellers and buyers of advertising and marketing services. The trami has members mainly of general women aged 20 to 40 who use social networking services (SNS), and members themselves experience client products and services. It is a service that publishes word-of-mouth and reviews on the SNS that you use. The main clients are companies that handle products (consumables) that women regularly purchase, such as skin care, makeup, daily necessities, health foods/supplements and others, mainly through agents.